CA1271199C - - Google Patents

Info

Publication number
CA1271199C
CA1271199C CA 436838 CA436838A CA1271199C CA 1271199 C CA1271199 C CA 1271199C CA 436838 CA436838 CA 436838 CA 436838 A CA436838 A CA 436838A CA 1271199 C CA1271199 C CA 1271199C
Authority
CA
Canada
Prior art keywords
bromine
chlorine
bases
compounds
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA 436838
Other languages
English (en)
Other versions
CA1257595A (fr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to CA000599049A priority Critical patent/CA1271199A/fr
Publication of CA1257595A publication Critical patent/CA1257595A/fr
Application granted granted Critical
Publication of CA1271199C publication Critical patent/CA1271199C/xx
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/04—Saturated ethers
    • C07C43/13—Saturated ethers containing hydroxy or O-metal groups
    • C07C43/135—Saturated ethers containing hydroxy or O-metal groups having more than one ether bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/08—Saturated compounds containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pyridine Compounds (AREA)
CA000436838A 1982-09-17 1983-09-16 Derives de 5-halogenovinyl-2'-desoxyuridine Expired CA1257595A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000599049A CA1271199A (fr) 1982-09-17 1989-05-08 Cyclopentanols proteges

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8226515 1982-09-17

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA000599049A Division CA1271199A (fr) 1982-09-17 1989-05-08 Cyclopentanols proteges

Publications (2)

Publication Number Publication Date
CA1257595A CA1257595A (fr) 1989-07-18
CA1271199C true CA1271199C (fr) 1990-07-03

Family

ID=10532974

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000436838A Expired CA1257595A (fr) 1982-09-17 1983-09-16 Derives de 5-halogenovinyl-2'-desoxyuridine

Country Status (17)

Country Link
US (1) US4564618A (fr)
EP (1) EP0104066B1 (fr)
JP (1) JPS5980620A (fr)
AT (1) ATE36325T1 (fr)
AU (2) AU575022B2 (fr)
CA (1) CA1257595A (fr)
CZ (1) CZ402691A3 (fr)
DE (1) DE3377647D1 (fr)
DK (1) DK160271C (fr)
ES (2) ES525670A0 (fr)
GB (1) GB2129425B (fr)
HK (1) HK84190A (fr)
IE (1) IE55921B1 (fr)
MX (1) MX9203234A (fr)
NZ (1) NZ205619A (fr)
SG (1) SG68890G (fr)
ZA (1) ZA836902B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4719214A (en) * 1985-07-25 1988-01-12 Southern Research Institute Carbocyclic analogues of thymine nucleosides
PT83201A (en) * 1985-08-16 1986-09-01 Glaxo Group Ltd Guanine derivatives
US5215970A (en) * 1987-04-16 1993-06-01 Medivir Ab Nucleosides and nucleotide analogues, pharmaceutical composition and processes for the preparation of the compounds
EP0516186A3 (en) * 1987-04-16 1993-01-13 Medivir Aktiebolag Nucleosides and nucleoside analogues, pharmaceutical composition and processes for the preparation of the compounds
US4863927A (en) * 1987-05-11 1989-09-05 Merck & Co., Inc. 1-(2-hydroxymethyl)cycloalkylmethyl)-5-substituted uracils
GB8920457D0 (en) * 1989-09-11 1989-10-25 Glaxo Group Ltd Chemical compounds
USH1142H (en) 1990-11-05 1993-02-02 Optically active cyclobutyl pyrimidine

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS606943B2 (ja) * 1975-04-01 1985-02-21 三井製薬工業株式会社 １−（α−アルコキシアルキル）−ウラシル類の製造法
US4177348A (en) * 1977-12-13 1979-12-04 United States Government Carbocyclic analogs of cytosine nucleosides
US4232154A (en) * 1977-12-13 1980-11-04 United States Of America Carbocyclic analogs of cytosine nucleosides exhibiting antiviral and antineoplasticactivity
GB1601020A (en) * 1978-04-24 1981-10-21 Stichting Grega Vzw 2'-deoxy-5 (2-halogenovinyl)-uridines
GB2060604B (en) * 1979-10-03 1983-11-23 Univ Birmingham And Stichting E15-(2-halogenovinyl)-2'-deoxycytidines
JPS5738774A (en) * 1980-08-19 1982-03-03 Chugai Pharmaceut Co Ltd Uracil derivative and its preparation
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
NZ199764A (en) * 1981-03-20 1984-08-24 Beecham Group Plc 5-(2-halogenovinyl)-2'-deoxyuridine derivatives and pharmaceutical compositions
EP0072137A1 (fr) * 1981-08-01 1983-02-16 Beecham Group Plc Déoxyuridines à activité antivirale
US4396623A (en) * 1981-08-26 1983-08-02 Southern Research Institute Carbocyclic analogs of uracil nucleosides as antiviral agents
HU183567B (en) * 1981-09-07 1984-05-28 Mta Koezponti Kemiai Kutato In Process for preparing /e/-5-/2-bromo-vinyl/-uridine and derivatives thereof
JPS5843993A (ja) * 1981-09-09 1983-03-14 Yamasa Shoyu Co Ltd １−β−Ｄ−アラビノフラノシル−（Ｅ）−５−（２−ハロゲノビニル）ウラシル−５′−りん酸およびその製造法
EP0080305A1 (fr) * 1981-11-19 1983-06-01 Beecham Group Plc 2'-Déoxyuridines à activité antivirale, leur préparation et emploi
EP0082668A1 (fr) * 1981-12-18 1983-06-29 Beecham Group Plc 5-(2-Halogénovinyl)-2'-déoxyuridines, leurs méthodes de préparation, compositions pharmaceutiques les contenant et leur emploi dans le traitement d'infections virales
DE3620646A1 (de) * 1986-06-20 1987-12-23 Bayer Ag Verfahren zur herstellung von (1r, 4s)-4-hydroxy-2-cyclopentenylestern

Also Published As

Publication number Publication date
CA1257595A (fr) 1989-07-18
ZA836902B (en) 1985-05-29
ES532056A0 (es) 1985-08-01
EP0104066B1 (fr) 1988-08-10
GB2129425A (en) 1984-05-16
MX9203234A (es) 1992-07-01
ES8506751A1 (es) 1985-08-01
ATE36325T1 (de) 1988-08-15
CZ402691A3 (en) 1993-07-14
IE55921B1 (en) 1991-02-27
ES8502978A1 (es) 1985-02-01
AU575022B2 (en) 1988-07-21
DK160271B (da) 1991-02-18
DK422183A (da) 1984-03-18
HK84190A (en) 1990-10-25
DK160271C (da) 1991-07-22
US4564618A (en) 1986-01-14
DK422183D0 (da) 1983-09-16
AU1918583A (en) 1984-03-22
GB8324813D0 (en) 1983-10-19
AU601583B2 (en) 1990-09-13
EP0104066A2 (fr) 1984-03-28
JPS5980620A (ja) 1984-05-10
SG68890G (en) 1990-10-26
GB2129425B (en) 1987-02-11
NZ205619A (en) 1987-09-30
EP0104066A3 (en) 1984-06-06
IE832175L (en) 1984-03-17
ES525670A0 (es) 1985-02-01
DE3377647D1 (de) 1988-09-15
AU1646588A (en) 1988-08-11

Similar Documents

Publication Publication Date Title
ES8700851A1 (es) Procedimiento para la obtencion de acido alquil-1- ciclopropil-1, 4-dihidro-4-oxo-3-quinolincarboxilico.
ES8802148A1 (es) Procedimiento para preparar derivados de acido quinoloncarboxilico
ES469265A1 (es) Procedimiento para la fabricacion de derivados del acido omega-aminoacilamisulfonico
ES8506594A1 (es) Un procedimiento para obtener derivados de indanilbenzamida
CA1271199C (fr)
EP0144991A3 (en) Polymethosybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
ES484524A1 (es) Procedimiento para la obtencion de derivados de 1-azolil-1- fluorfenoxibutano de efecto fungicida
CA1271748C (fr) Derives de benzazepine
ES479833A1 (es) Un procedimiento para preparar mercatoacilaminoacidos susti-tuidos con halogeno.
ES474367A1 (es) Procedimiento de preparacion de nuevos derivados del benzo- (d)tiazol.
ES8801805A1 (es) Procedimiento para la obtencion de nuevos derivados de isoxazol
ES8504829A1 (es) Un procedimiento para la preparacion de un acido -hidroxietilfosfinico
ES461779A1 (es) Procedimiento para la preparacion de lariloxi-3-amino-3-pro-panoles.
ES8401488A1 (es) Procedimiento de preparacion de derivados de diaza-3,7a-cicloherta-(j,k)-fluorenos.
ES473465A1 (es) Procedimiento para la preparacion de triazolo-tieno-diazepin-1-onas
IE44764L (en) Ferrocene derivatives.
GB1491434A (en) 3-aminomethyl-4-homoisotwistane and acid addition salts thereof
ES8308335A1 (es) Un procedimiento para la preparacion de nuevos derivados de desoxiuridina.
JPS5414961A (en) Novel 3-hydroxyazetidine-3-carboxylic derivative
SU1394659A1 (ru) Стабилизатор хлорсодержащих углеводородов
TH2688EX (th) สารประกอบเบนโซอิลเยูเรียที่ใช้ฆ่าตัวรังควาน

Legal Events

Date Code Title Description
MKEX Expiry